For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

14 May 2009
Two new Drug Use Evaluation (DUE) tools have been developed by the National Prescribing Service Ltd (NPS) to assist health professionals working in aged care facilities with optimal drug therapy relating to laxative use, and hypnotics.
The NPS DUE toolkits provide localised activities to compare current drug use against best practice and guide health professionals in their decision making to achieve the best outcomes for patients.
“Laxatives are one of the most frequently used medicines in long term aged care facilities - up to half of nursing home residents have reported experiencing constipation and 74% are receiving at least one laxative preparation[1],” NPS Education and Quality Assurance Program Manager, Judith Mackson said.
“But despite their widespread use, it is often difficult to assess the efficacy of laxatives. The inappropriate treatment of constipation can have a significant impact on the resident’s quality of life and increase the cost of care. The Laxative use for chronic constipation DUE will support health professionals to ascertain if current practice is at odds with best practice,” Ms Mackson said.
Benzodiazepine and non-benzodiazepine hypnotics for insomnia is the first electronic DUE toolkit to be available as a downloadable application for health professionals. The tool is a standalone data collection and analysis tool which is a valuable addition to the DUE resources.
This eDUE examines the appropriate use of medicines to manage insomnia in aged care facilities. The new electronic format contains fewer questions than other DUE tools, offers an intuitive interface and a variety of drop down menus. It also has a ‘save as you go’ mechanism, recognises appropriate dosage quantities and provides automatic feedback.
There are now four DUE toolkits available from NPS:
Participation in these DUE activities will assist the aged care facility to meet components of the Residential Care Standards issued by the Aged Care Standards and Accreditation Agency and comply with the Australian Pharmaceutical Advisory Council Guidelines for medication management in Residential Aged Care Facilities.
These DUE activities are also recognised by a number of health professional bodies as contributing to continuing education and professional development. To be eligible for professional development points, enter your details on the DUE access page on the NPS website.
The NPS DUE toolkits are downloadable at www.nps.org.au/due. For more information about DUE in aged care facilities, contact Aine Heaney at NPS on (02) 8217 8700 or info@nps.org.au.
ENDS
The National Prescribing Service Limited (NPS) is an independent, non-profit organisation for Quality Use of Medicines funded by the Australian Government Department of Health and Ageing.
1. Harari D, Gurwitz JH, Avorn J, et al. Bowel habit in relation to age and gender: findings from the National Health interview Survey and clinical implications. Arch Int Med 1996;156:315-20.
2. Williams SG, DiPalma JA. Constipation in the long-term care facility. Gastroenterol Nurs.1990;12:179-82.
3.Woodward M, Moran J, Elliot R, et al. Constipation in older people Pharmacological Management Issue. J Pharm Pract Res 2002;32:37-43.
Media enquiries
Contact us
Date published: 2009-05-15 19:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.